首页> 外文期刊>日本臨牀 >Immune reconstitution after allogeneic stem cell transplantation using nonmyeloablative or reduced-intensity conditioning regimen
【24h】

Immune reconstitution after allogeneic stem cell transplantation using nonmyeloablative or reduced-intensity conditioning regimen

机译:使用非清髓或降低强度的调节方案进行同种异体干细胞移植后的免疫重建

获取原文
获取原文并翻译 | 示例
           

摘要

A number of reduced-intensity conditioning(RIC) regimens, which mainly consisted of potent immunosuppressive agents but not of myeloablative agents, has been explored in order to achieve successful engraftment and subsequent graft-versus-leukemia/tumor effect. Because of the decreased regimen-related toxicity, RIC regimens have replaced myeloablative regimens, particularly for those who are not eligible for high dose chemoradiotherapy due to advanced age or organ dysfunction. However, allogeneic stem cell transplantation(allo-SCT) using RIC regimens sometimes end up with mixed chimerism and may require donor-lymphocyte infusion to achieve complete chimera. Furthermore, strong immunosuppressive agents used in RIC regimens might contribute to the delayed immune recovery after allo-SCT, which might subsequently increase the incidence of infections. These findings suggest that the hematopoietic and immune reconstitution after allo-SCT using RIC regimens is different from that using conventional regimen. Inthis article, hematopoietic reconstitution, phenotypic analysis of lymphocytes, infections, and graft-versus-host disease after allo-SCT using RIC regimens are discussed, comparing with those using conventional regimens.
机译:为了实现成功的移植和随后的移植物抗白血病/肿瘤效应,已经研究了许多降低强度的调理(RIC)方案,这些方案主要由有效的免疫抑制剂而不是清髓剂组成。由于与方案相关的毒性降低,RIC方案已取代清髓性方案,特别是对于那些由于年老或器官功能不全而无法进行高剂量放化疗的患者。然而,使用RIC方案的同种异体干细胞移植(allo-SCT)有时会导致混合嵌合,并且可能需要注入供体淋巴细胞才能达到完全嵌合。此外,RIC方案中使用的强免疫抑制剂可能会导致异源SCT后的免疫恢复延迟,从而可能随后增加感染发生率。这些发现表明,使用RIC方案的allo-SCT后的造血和免疫重建与使用常规方案的不同。在本文中,讨论了使用RIC方案进行异源SCT后的造血重建,淋巴细胞表型分析,感染以及移植物抗宿主病,并与常规方案进行了比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号